| BCBS Texas Medical Policies | Inebilizumab-cdon | 2026-05-01 |
| BCBS Texas Medical Policies | Natalizumab and Associated Biosimilar(s) | 2026-05-01 |
| BCBS Texas Medical Policies | Negative Pressure Wound Therapy in the Outpatient Setting | 2026-05-01 |
| BCBS Texas Medical Policies | Nerve Graft with Radical Prostatectomy | 2026-05-01 |
| BCBS Texas Medical Policies | Noncontact Normothermic Wound Therapy (NNWT) | 2026-05-01 |
| BCBS Texas Medical Policies | Nonpharmacologic Treatment of Rosacea | 2026-05-01 |
| BCBS Texas Medical Policies | Octreotide acetate | 2026-05-01 |
| BCBS Texas Medical Policies | Ublituximab-xiiy | 2026-05-01 |
| BCBS Texas Medical Policies | Use of a Medial Knee Implantable Shock Absorber | 2026-05-01 |
| BCBS Texas Medical Policies | Uterus Transplantation for Absolute Uterine Factor Infertility | 2026-05-01 |